BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 23551890)

  • 1. Subthalamic deep brain stimulation improves smooth pursuit and saccade performance in patients with Parkinson's disease.
    Nilsson MH; Patel M; Rehncrona S; Magnusson M; Fransson PA
    J Neuroeng Rehabil; 2013 Apr; 10():33. PubMed ID: 23551890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Subthalamic Nucleus in Inhibitory Control of Oculomotor Behavior in Parkinson's Disease.
    Bakhtiari S; Altinkaya A; Pack CC; Sadikot AF
    Sci Rep; 2020 Mar; 10(1):5429. PubMed ID: 32214128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.
    Dec-Ćwiek M; Tutaj M; Gracies JM; Volkmann J; Rudzińska M; Słowik A; Szczudlik A
    Neurol Neurochir Pol; 2017; 51(5):354-360. PubMed ID: 28669542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms.
    Pinkhardt EH; Jürgens R; Lulé D; Heimrath J; Ludolph AC; Becker W; Kassubek J
    BMC Neurol; 2012 Feb; 12():5. PubMed ID: 22375860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease.
    Goelz LC; David FJ; Sweeney JA; Vaillancourt DE; Poizner H; Metman LV; Corcos DM
    Exp Brain Res; 2017 Feb; 235(2):615-626. PubMed ID: 27844097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pedunculopontine and Subthalamic Nucleus Stimulation Effect on Saccades in Parkinson Disease.
    Khan AN; Bronstein A; Bain P; Pavese N; Nandi D
    World Neurosurg; 2019 Jun; 126():e219-e231. PubMed ID: 30797925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subthalamic deep brain stimulation on turning kinematics and related saccadic eye movements in Parkinson disease.
    Lohnes CA; Earhart GM
    Exp Neurol; 2012 Aug; 236(2):389-94. PubMed ID: 22580213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye movement-related responses of neurons in human subthalamic nucleus.
    Fawcett AP; Dostrovsky JO; Lozano AM; Hutchison WD
    Exp Brain Res; 2005 Apr; 162(3):357-65. PubMed ID: 15599721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease.
    Yugeta A; Terao Y; Fukuda H; Hikosaka O; Yokochi F; Okiyama R; Taniguchi M; Takahashi H; Hamada I; Hanajima R; Ugawa Y
    Neurology; 2010 Mar; 74(9):743-8. PubMed ID: 20194913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation improves survival in severe Parkinson's disease.
    Ngoga D; Mitchell R; Kausar J; Hodson J; Harries A; Pall H
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):17-22. PubMed ID: 23843542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation.
    Rocchi L; Carlson-Kuhta P; Chiari L; Burchiel KJ; Hogarth P; Horak FB
    J Neurosurg; 2012 Dec; 117(6):1141-9. PubMed ID: 23039143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.
    Blahak C; Wöhrle JC; Capelle HH; Bäzner H; Grips E; Weigel R; Hennerici MG; Krauss JK
    J Neurol; 2007 Feb; 254(2):169-78. PubMed ID: 17334951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral deep brain stimulation of the subthalamic nucleus increases pointing error during memory-guided sequential reaching.
    David FJ; Goelz LC; Tangonan RZ; Metman LV; Corcos DM
    Exp Brain Res; 2018 Apr; 236(4):1053-1065. PubMed ID: 29427240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
    Gierthmühlen J; Arning P; Binder A; Herzog J; Deuschl G; Wasner G; Baron R
    Mov Disord; 2010 Jul; 25(9):1195-202. PubMed ID: 20629160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.